Prediction of severe community-acquired pneumonia: A systematic review and meta-analysis

Critical Care

Volumn 16, Issue 4, 2012, Pages

  Marti, Christophe ^a   Garin, Nicolas ^a,b   Grosgurin, Olivier ^a   Poncet, Antoine ^c   Combescure, Christophe ^c   Carballo, Sebastian ^a   Perrier, Arnaud ^a  

^a Hopital de Geriatrie   (Switzerland)

^b Regional Hospital of Chablais   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; BREATHING RATE; COCHRANE LIBRARY; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION, RESPIRATORY RATE, BLOOD PRESSURE, AGE 65 SCORE; DISEASE REGISTRY; DISEASE SEVERITY; EMBASE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MEDLINE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEVERE COMMUNITY ACQUIRED PNEUMONIA SCORE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; COMMUNITY-ACQUIRED INFECTIONS; HOSPITAL MORTALITY; META ANALYSIS; PATHOLOGY; PNEUMONIA; SEVERITY OF ILLNESS INDEX;

COMMUNITY-ACQUIRED INFECTIONS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; PATIENT ADMISSION; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84864268283     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11447     Document Type: Article

References (63)

1. Marston BJ, Plouffe JF, File TM, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio: The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997, 157:1709-1718. 10.1001/archinte.1997.00440360129015, 9250232.
2. Ewig S, Torres A. Severe community-acquired pneumonia. Clin Chest Med 1999, 20:575-587. 10.1016/S0272-5231(05)70237-9, 10516905.
3. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250. 10.1056/NEJM199701233360402, 8995086.
4. Chalfin DB, Trzeciak S, Likourezos A, Baumann BM, Dellinger RP. Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med 2007, 35:1477-1483. 10.1097/01.CCM.0000266585.74905.5A, 17440421.
5. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008, 133:610-617. 10.1378/chest.07-1456, 17989157.
6. Renaud B, Santin A, Coma E, Camus N, Van Pelt D, Hayon J, Gurgui M, Roupie E, Herve J, Fine MJ, Brun-Buisson C, Labarere J. Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia. Crit Care Med 2009, 37:2867-2874. 10.1097/CCM.0b013e3181b02dbb, 19770748.
7. Niederman MS, Bass JB, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy: American Thoracic Society, Medical Section of the American Lung Association. Am Rev Respir Dis 1993, 148:1418-1426.
8. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754.
9. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72.
10. Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Grayson ML. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008, 47:375-384. 10.1086/589754, 18558884.
11. Espana PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006, 174:1249-1256. 10.1164/rccm.200602-177OC, 16973986.
12. Renaud B, Labarere J, Coma E, Santin A, Hayon J, Gurgui M, Camus N, Roupie E, Hemery F, Herve J, Salloum M, Fine MJ, Brun-Buisson C. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care (London) 2009, 13:R54.
13. Worster A, Carpenter C. Incorporation bias in studies of diagnostic tests: how to avoid being biased about bias. Canadian J Emerg Med 2008, 10:174-175.
14. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006, 144:427-437.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
17. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12:1293-1316.
18. Lamy O, Van Melle G, Cornuz J, Burnand B. Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia. Eur J Intern Med 2004, 15:28-34. 10.1016/j.ejim.2003.11.003, 15066645.
19. Ewig S, Seifert K, Kleinfeld T, Goke N, Schafer H. Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation. Respir Med 2000, 94:556-563. 10.1053/rmed.1999.0775, 10921759.
20. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, Jackson R, Schousboe M, Frampton C, Hutton S, Chambers ST, Town GI. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996, 51:1010-1016. 10.1136/thx.51.10.1010, 472650, 8977602.
21. Ananda-Rajah MR, Charles PGP, Melvani S, Burrell LL, Johnson PDR, Grayson ML. Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. Scand J Infect Dis 2008, 40:293-300. 10.1080/00365540701663381, 17918017.
22. Angus DC, Marrie TJ, Scott Obrosky D, Clermont G, Dremsizov TT, Coley C, Fine MJ, Singer DE, Kapoor WN. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria. Am J Respir Crit Care Med 2002, 166:717-723. 10.1164/rccm.2102084, 12204871.
23. Brown SM, Jones BE, Jephson AR, Dean NC. Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med 2009, 37:3010-3016. 10.1097/CCM.0b013e3181b030d9, 2783880, 19789456.
24. Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006, 61:419-424. 10.1136/thx.2005.051326, 2111174, 16449258.
25. Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007, 19:418-426. 10.1111/j.1742-6723.2007.01003.x, 17919214.
26. Calbo E, Ochoa de Echaguen A, Rodriguez-Carballeira M, Ferrer C, Garau J. Hospital admission, duration of stay and mortality in community-acquired pneumonia in an acute care hospital: correlation between a pneumonia prognosis index and conventional clinical criteria for assessing severity. Enferm Infecc Microbiol Clin 2004, 22:64-69. 10.1157/13056884, 14756986.
27. Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, Bilbao A. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006, 27:151-157. 10.1183/09031936.06.00062505, 16387948.
28. Chalmers JD, Singanayagam A, Hill AT. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 2008, 63:698-702. 10.1136/thx.2008.095562, 18492742.
29. Davis JS, Cross GB, Charles PG, Currie BJ, Anstey NM, Cheng AC. Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply?. Med J Aust 2010, 192:133-136.
30. Escobar GJ, Fireman BH, Palen TE, Gardner MN, Lee JY, Clark MP, Kipnis P. Risk adjusting community-acquired pneumonia hospital outcomes using automated databases. Am J Manag Care 2008, 14:158-166.
31. Espana PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacain R, Menendez R, Torres A. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia. J Infect 2010, 60:106-113. 10.1016/j.jinf.2009.11.013, 19961875.
32. Ewig S, de Roux A, Bauer T, Garcia E, Mensa J, Niederman M, Torres A. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004, 59:421-427. 10.1136/thx.2003.008110, 1747015, 15115872.
33. Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, Niederman MS, Torres A. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 1998, 158:1102-1108.
34. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ 2000, 162:1415-1420. 1232453, 10834044.
35. Frei CR, Burgess DS. Community-acquired pneumonia: objective criteria to predict severe disease. J Infect Dis Pharmacother 2004, 6:39-48.
36. Garau J, Baquero F, Perez-Trallero E, Perez JL, Martin-Sanchez AM, Garcia-Rey C, Martin-Herrero JE, Dal-Re R. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008, 14:322-329. 10.1111/j.1469-0691.2007.01915.x, 18190569.
37. Garcia-Vidal C, Fernandez-Sabe N, Carratala J, Diaz V, Verdaguer R, Dorca J, Manresa F, Gudiol F. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008, 32:733-739. 10.1183/09031936.00128107, 18508820.
38. Kamath A, Pasteur MC, Slade MG, Harrison BD. Recognising severe pneumonia with simple clinical and biochemical measurements. Clin Med 2003, 3:54-56.
39. Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piner R, Mensa J, Luque N, Ewig S, Menendez R, Niederman MS, Torres A. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 2009, 48:377-385. 10.1086/596307, 19140759.
40. Man SY, Lee N, Ip M, Antonio GE, Chau SS, Mak P, Graham CA, Zhang M, Lui G, Chan PK, Ahuja AT, Hui DS, Sung JJ, Rainer TH. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007, 62:348-353. 10.1136/thx.2006.069740, 2092476, 17121867.
41. Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) 2007, 86:103-111.
42. Phua J, See KC, Chan YH, Widjaja LS, Aung NW, Ngerng WJ, Lim TK. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 2009, 64:598-603. 10.1136/thx.2009.113795, 19386583.
43. Putinati S, Ballerin L, Piattella M, Ritrovato L, Zabini F, Potena A. Clinical policy for management and risk stratification of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Rec Progr Med 2003, 94:199-203.
44. Renaud B, Coma E, Hayon J, Gurgui M, Longo C, Blancher M, Jouannic I, Betoulle S, Roupie E, Fine MJ. Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study. Clin Microbiol Infect 2007, 13:923-931. 10.1111/j.1469-0691.2007.01772.x, 17617186.
45. Riley PD, Aronsky D, Dean NC. Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia. Crit Care Med 2004, 32:2398-2402. 10.1097/01.CCM.0000147443.38234.D2, 15599142.
46. Roson B, Carratala J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001, 33:158-165. 10.1086/321808, 11418874.
47. Shah BA, Ahmed W, Dhobi GN, Shah NN, Khursheed SQ, Haq I. Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting. Indian J Chest Dis 2010, 52:9-17.
48. van der Eerden MM, de Graaff CS, Bronsveld W, Jansen HM, Boersma WG. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia. Respir Med 2004, 98:872-878. 10.1016/j.rmed.2004.02.022, 15338800.
49. Fukuyama H, Ishida T, Tachibana H, Nakagawa H, Iwasaku M, Saigusa M, Yoshioka H, Arita M, Hashimoto T. Validation of scoring systems for predicting severe community-acquired pneumonia. Intern Med 2011, 50:1917-1922. 10.2169/internalmedicine.50.5279, 21921369.
50. Chalmers JD, Taylor JK, Mandal P, Choudhury G, Singanayagam A, Akram AR, Hill AT. Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients Without Major Criteria or Contraindications to Intensive Care Unit Care. Clin Infect Dis 2011, 53:503-511. 10.1093/cid/cir463, 21865188.
51. Putinati S, Ballerin L, Zabini F, Piattella M, Ritrovato L, Simoni M, Potena A. Predictive rules for prognosis in community-acquired pneumonia. Minerva Pneumol 2005, 44:85-91.
52. Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guerin T, Carre E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 2007, 44:41-49. 10.1086/509331, 17143813.
53. Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, Wood V, Hill AT. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia: systematic review and meta-analysis. Thorax 2010, 65:878-883. 10.1136/thx.2009.133280, 20729231.
54. Schuetz P, Suter-Widmer I, Chaudri A, Christ-Crain M, Zimmerli W, Mueller B. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011, 37:384-392. 10.1183/09031936.00035610, 20595156.
55. Schuetz P, Christ-Crain M, Zimmerli W, Mueller B. Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia. Intensive Care Med 2011, 37:970-980. 10.1007/s00134-011-2208-2, 21394616.
56. Kruger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia: influence of antibiotic pre-treatment: results from the German competence network CAPNETZ. J Antimicrob Chemother 2009, 64:159-162. 10.1093/jac/dkp148, 19403654.
57. Christ-Crain M, Breidthardt T, Stolz D, Zobrist K, Bingisser R, Miedinger D, Leuppi J, Tamm M, Mueller B, Mueller C. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. J Intern Med 2008, 264:166-176. 10.1111/j.1365-2796.2008.01934.x, 18298480.
58. Kruger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 2010, 65:208-214. 10.1136/thx.2009.121178, 20335288.
59. Christ-Crain M, Morgenthaler NG, Stolz D, Muller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Muller B. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 2006, 10:R96. 10.1186/cc4955, 1550935, 16805922.
60. Chalmers JD, Mandal P, Singanayagam A, Akram AR, Choudhury G, Short PM, Hill AT. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med 2011, 37:1409-1420. 10.1007/s00134-011-2261-x, 21660535.
61. Spindler C, Ortqvist A. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006, 28:816-823. 10.1183/09031936.06.00144605, 16737983.
62. Kontou P, Kuti JL, Nicolau DP. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae. Am J Emerg Med 2009, 27:968-974. 10.1016/j.ajem.2008.07.037, 19857416.
63. Feldman C, Alanee S, Yu VL, Richards GA, Ortqvist A, Rello J, Chiou CC, Chedid MB, Wagener MM, Klugman KP. Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care. Clin Microbiol Infect 2009, 15:850-857. 10.1111/j.1469-0691.2009.02901.x, 19702589.